Remain compliant and safeguard your patients

As Pharmacovigilance Service Provider we can meet all your clinical trial and post-authorisation needs!

 

 

Submit an RFI         Contact Us

The three steps to compliance:

icon_Submit RFI_v2

Submit an RFI >

  • Secure a meeting with our experts
  • Put in place a CDA/NDA
  • Specify your needs and requests 
  • Our specialist will guide you to a tailored outsourcing solution
icon_parnter_v2

Part of your team >

  • Kick-off meeting and selection of the preferred approach
  • QVigilance resources assigned to your team to meet your regulatory needs
  • Excellent customer care
icon_compliance

Compliance Achieved!

  • All your regulatory and business requirements are meet
  • Your PV system is in perfect compliance with EMA and FDA's regulations
  • You acquired a trusted partner, and we stay at your disposal for any future needs

OUR SERVICE OFFER

Global Pharmacovigilance Service Provider

EU PHARMACOVIGILANCE SERVICES

QPPV, PSMF & EUDRAVIGILANCE

OUR TECHNOLOGY SYSTEM: ARGUS DATABASE

Compliant Safety Systems

QVigilance can set up and host your global safety database on our E2B-R3 ready validated Oracle Argus 8.1 system which is compliant with the latest reporting requirements. We also provide our iQ customer portal where documents can be easily accessed and managed.

Request a consultation and speak with our PV experts!

 

Submit an RFI

QVIGILANCE BLOG

Explore our latest blog posts

5977730031

UK Draft Contingency released for ...

13 Feb, 2019

The UK government has released draft legislation amending the regulation of authorised Medicinal Products, Medical Devices and Clinical Trials, to be implemented in the event that the UK leaves the European Union (EU) ...

Read More

‘No deal’ Brexit regulatory advice ...

06 Dec, 2018

In this 'Brexit News' close-up our Regulatory Intelligence team will provide a commentary and updates on recent British Government briefing around Brexit implication on medicines, devices and clinical trials. Also, will ...

Read More

Pharmacovigilance in the European ...

06 Dec, 2018

To ensure a smooth transition from the pre-authorisation to the post-authorisation phase of the life-cycle of a medicinal product, it is the responsibility of the Marketing Authorisation (MA) applicant to have in place ...

Read More